The advent of "high-performance" liquid chromatography (HPLC) revolutionized the technology for the separation of simple organic molecules, and today HPLC is a part of the routine equipment of many clinical laboratories.
However, the rapid separation of proteins by HPLC has yet to be developed into a system that can provide high resolution over the wide range of protein types (enzymes, plasma proteins, and hemoglobin) required for the diagnosis and monitoring of disease. Recent advances in HPLC techniques have led to preliminary reports on the separation of blood and urine proteins through use of size-exclusion gels designed for HPLC (1) (2) (3) .
A novel approach to the problems of rapid separation of proteins has been devised by Pharmacia Fine Chemicals,
Uppsala,
Sweden, which in 1982 introduced the Fast Protein Liquid Chromatography system (FPLC). At the heart of the system are the newly developed MonobeadTM columns; the key elements in these three types of columns are the uniform monodisperse spheres, which give excellent separation and flow characteristics at only a moderately increased FPLC, a general-purpose system for protein separation, was not specifically designed for clinical research. However, initial studies of the separation of urinary proteins (5) and of several plasma proteins suggested that this form of chromatography might allow rapid identification of protein profiles or microvariability within a single protein, which could be of clinical significance (6) .
In this paper we illustrate some applications of FPLC in the separation of urinary and cerebrospinal fluid (CSF) proteins, which were developed after our initial study of the optimization of a buffer system for the separation of urinary proteins on the anion exchanger (5).
Methods and Materials
Clinical samples. Urines were from patients with a variety of diseases causing tubular proteinuria, or renal failure, and patients with myelomatosis. The latter patients were all excreting light chains in the urine in concentrations >2 g/L. Cerebrospinal fluid. We obtained 50 samples from adults and children with acute leukemia. Albumin content was in the range of 100-1500 mg/L (45% being >300 mg/L), and IgG was 10-1000 mg/L (41% being >35 mg/L). Only three samples contained detectable amounts of hemoglobin. Ten more samples of CSF containing blood were examined from patients with a recent cerebral hemorrhage, and five xanthochromic CSFs were obtained from patients several days after a bleed into the CSF.
Chromatography.
All the chromatographic equipment used in these studies was manufactured by Pharmacia. The FPLC system consists of a GP-250 gradient programmer controlling two P-500 reciprocating pumps-each pump delivers one buffer into a dynamic mixing chamber where the buffers then pass through a filter-and a manually packed at 4 MPa with a P-500 pump as previously described We tried direct application of the CSF to the anionexchange column, but found that definition of the protein peaks was improved by preliminary salt exchange.
Buffers. The start buffer (buffer A) for the anion exchanger column was Bis-Tris (Sigma London Chemical Co., Ltd.), 6.25 mmol/L, pH 7.50. The eluting buffer was buffer A plus 0.35 mol of NaC1 per liter at pH 9.50. A uniform elution gradient was produced by going from 100% buffer A to 100% buffer B over a volume of 25 mL.
Initially the choice of buffer, which was originally devised for urinary proteins, was determined by comparison of electrophoretic titration curves (5). However, it also appeared to provide reasonable separation of the plasma proteins in CSF when applied to the anion exchanger. Although this buffer may not be ideal, we used it here as the standard against which improvements in the resolution of individual proteins or profiles of groups of reference proteins could be compared.
The flow rate of the buffers during the elution was 2 mId mm in all the separations.
Immunochemical methods.
The concentration of individual proteins was measured by single radial immunodiffusion (7), and the retention times and retention widths of the proteins were confirmed by fused rocket immunoelectrophoresis (8) with antisera from various sources (Pharmacia;
Atlantic Antibodies, Scarborough, ME 04074; Behringwerke, Marburg/Lahn, F.R.G.; Seward, London, U.K.). We determined the purity of the eluted fractions by crossed immunoelectrophoresis against antisera to whole human proteins; individual plasma proteins were identified with appropriate monospecific antisera in the intermediate gel (9).
Precolumn
procedures.
The G25 precolumns can separate the protein fraction from the large excess of low-Mr compounds that have a strong absorbance at 280 nm. height in eight aliquots of the same urine, indicated a CV of 4.0%.
Separation performance.
Twenty urines taken from patients with tubular, glomerular, and mixed glomerular and tubular proteinuria were used as starting material to check the separation of the proteins on the anion-exchange colwnn. The positions of b4 proteins were identified by the fused rocket technique. Later, using a pool of CSF from 10 patients with increased total CSF proteins, we repeated this procedure and identified seven more proteins. There was no difference in the retention times of a protein whether it was isolated from CSF or urine. The distribution of these retention times is shown in Table 1 . With a few exceptions, such as IgA, their elution order closely matches their electrophoretic mobility.
Reproducibility.
Certain forms or proteinuria, especially tubular proteinuria, produce chromatograms with relatively few well-defined peaks, as shown in Figure 2 . To check the reproducibility of protein position and peak heights, we used a urine sample from a patient with tubular proteinuria; proteins in that sample could be resolved into eight peaks by the FPLC technique. The results of eight consecutive analyses of the sample are shown in Table 2 . The between-assay variation, examined by calculating the distance between the peak of f32-microglobulin and albumin in 20 urine chromatograms, was 5.1%. The accuracy of the pumps and programmer, checked by inserting a conductivity meter into the system immediately after the ultraviolet monitor, was such that the variation in conductivity at any point in 20 replicate runs was <5%.
Pattern recognition. Eight repeated runs of the same urine to determine the CV of the peak position and peak heights, as measured by a Pharmacia LCC-500 peak analyzer.
aj-acid glycoprotein with a1-microglobulin. These features disappear when the lesion is reversible. As Figure 3 shows, the chromatographic trace of normal, unconcentrated urine has no peaks. Selective tubular dysfunction affecting the reabsorption of aj-microglobulin and a1-acid glycoprotein is a feature of recovery after burns and can also be produced by drugs such as cis-platinum. Large amounts of a1-acid glycoprotein with some increase in albumin is a feature of the chromatograms of the nonspecific proteinuria of fever. On the other hand, the patterns in mixed tubular and glomerular proteinuria cannot be so readily interpreted, because of the larger amounts of a wide range of plasma proteins present in the urine. These examples illustrate how FPLC is being used in the analysis of different forms of acute and chronic nephrotoxic damage. Milliliters after the start of the gradient. 5Serum creatinine >250 mol/L. All the light chains were monomeric, except those from patients 7 and 9, which were dimeric. e.g., f32-microglobulin, retinol-binding protein, and a1-acid glycoprotein (5). Polyclonal light chain, identified in the urine of patients with rheumatoid arthritis, was found to elute partly in the void volume and partly in a peak at 6 mL after starting the gradient. FPLC studies of the urines of 13 patients with myelomatosis who were excreting large amounts of monoclonal light chain indicated considerable variation in the elution profiles between kappa and lambda types of light chains as well as within each type. Examples of the single and double peaked elution profile are shown in Figures 4 and 5 , and the variation of the retention times is listed in Table 3 . Repeated examination of urine from two patients excreting monoclonal light chains showed that the retention time of an individual's light chain was unchanged during the evolution of the disease.
Urinary proteins.

Low-Mr
Proteins
in CSF. In contrast to urine protein profiles the patterns produced on chromatographing CSF were generally far more complicated. By aligning 50 chromatograms of CSF from patients with leukemia, taken during the monitoring of the central nervous system, irrespective of the clinical status, we could identilS' transferrin, albumin, and prealbumin as readily identifiable peaks eluting in a constant position. Hemorrhage was associated with a very sharp peak at 280 nm, eluting at 6 mL after starting the gradient. The predominant feature of the CSF chromatograms was the variability of the more basic protein peaks, mainly IgGs, which eluted in the first 10 mL. Several sharp peaks may occur in this region, probably corresponding to oligoclonal IgG; other proteins eluting in this region are present in only small amounts. The complexity of the CSF proteins and the fact that the buffers have not been optimized for IgG separation suggests that a further chromatographic step will be needed to reveal information that can readily be cross-correlated with the clinical status of the patient.
Preliminary studies of hemoglobin and its breakdown products in CSF suggest that FPLC could be a useful procedure in following the sequence of changes. Monitoring the CSF eluents at 405 rim, we have found that acute subarachnoid hemorrhage produces three main absorption peaks: free hemoglobin at 6 mL, heme bound to hemopexin at 11 mL, and hemoglobin bound to haptoglobin at 19 mL ( Figure  6 ). Denaturation of the hemoglobin can result in some of the hemoglobin eluting in the void volume. By contrast, xanthochromic CSF is associated with a single absorption peak that coelutes with albumin (probably bilirubin bound to albumin) and the hemoglobin peak can no longer be detected. 
Discussion
Plasma proteins elute from the anion-exchange column, in an order that, with some exceptions such as IgA, is close to their electrophoretic mobility. This is very helpful in planning subsequent investigations, because we can select specific antisera to investigate a given peak on the basis of standard tables of the characteristics of plasma proteins.
Preliminary studies of urine and CSF profiles reported here have shown that the anion-exchange column widely separates plasma proteins, which form the predominant component of the proteins in these fluids. The anion-exchange procedure appears to provide sharper peaks for protein profiles than do size-exclusion gels. Because of the range of mo'ecular masses of plasma proteins, they tend to cluster in broad zones when separated on size-exclusion columns.
Because of the sensitivity of the ultraviolet detectors and the efficiency of the anion-exchange column, a protein proffle can be obtained in volumes as small as 0.25 mL of unconcentrated CSF, especially when the total protein is greater than 500 mgfL. For CSF with a total protein content less than 500 mgfL, a 0.5-mL sample seems to be adequate.
The microheterogeneity of the proteins in the CSF did not appear to result in multiple peaks from the same protein, for IG bSib1y b't%Jrrin. We COflCIUi4O hal pan o?the IgG fraction is uncharged, part of it being found in the void volume when chromatographed on the anion-exchange columns.
The relationships between the elution patterns of IgG and their oligoclonal restriction in diseases such as disseminated sclerosis will require further study. Kjellin The novel feature of FPLC is its speed as compared with other methods of investigating complex profiles of proteins. The anion-exchange system is especially valuable for separating plasma proteins, and chromatofocusing
